Sevoflurane in acute myocardial infarction: a pilot randomized study.

Shahar Lavi1, Daniel Bainbridge1, Sabrina D'Alfonso2

  • 1Western University, London, Ontario, Canada; London Health Sciences Centre, London, Ontario, Canada.

American Heart Journal
|December 3, 2014
PubMed
Summary

Sevoflurane sedation did not reduce heart attack size in patients undergoing primary percutaneous coronary intervention (PCI). However, it improved ST-segment resolution, indicating better blood flow after PCI.

Related Concept Videos